Fiche d’information: directives de l’OMS pour dépister, soigner, et traiter les personnes atteintes de l’hépatite C

Cette fiche d’information résume brièvement les recommandations majeures des directives de l’OMS concernant le dépistage, le soin, et le traitement des personnes atteintes de l’hépatite C. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

Abonnez-vous à l'Alerte mensuelle de l'IDPC pour recevoir des informations relatives à la politique des drogues.

An estimated 150–180 million people are infected with hepatitis C globally; however, available hepatitis C treatments are complex and/or expensive, and many governments currently do not cover the costs of treatment. In April 2014, the World Health Organization published its first guidelines on screening, care, and treatment of hepatitis C infection to help government officials and healthcare providers in resource-limited settings establish effective programs to care for individuals infected with the virus.

This fact sheet briefly summarizes the guidelines’ major recommendations, including who should be offered screenings for hepatitis C infection, how to monitor and reduce liver damage in those who test positive, and how to treat patients co-infected with HIV.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.